| abstract |
The present invention provides a novel peroxome proliferator-activated receptor (PPARα) transcription activator useful for the treatment of dyslipidemia and the like. A 1H-pyrazolo [3,4-b] pyridine derivative represented by the formula (1) is provided. [R1 is H, halogen, alkyl, halogenated alkyl, alkoxy, unsubstituted / substituted phenyl, unsubstituted / substituted phenoxy or unsubstituted / substituted benzyloxy; R2 is a linear / branched alkyl group or cyclic alkyl R3 is linear / branched alkyl; R4 is carboxy, ethoxycarbonyl or a propionic acid group having alkyl in the linear / branched α-position; X is C or N] [Selection] None |